Many Breast Cancer Patients May Not Be Receiving Recommended Test
A new report finds widespread variations and frequent errors in HER2 testing — a procedure recommended for all patients with invasive breast cancer.

University of California San Francisco
A new report finds widespread variations and frequent errors in HER2 testing — a procedure recommended for all patients with invasive breast cancer.
UCSF leaders took the stage recently to promote interprofessional collaboration and call attention to health care disparities.
The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the University of California, San Francisco (UCSF) have been awarded $24.8 million over two years by the National Institutes of Health (NIH) to create a new resource for studying disease, health, and aging.
Five UCSF faculty scientists are among the 65 newly elected members to the Institute of Medicine (IOM), part of the National Academy of Sciences. Election to IOM is considered one of the highest honors in the fields of health and medicine. The new members were announced today (Oct. 12, 2009) at the IOM annual meeting.
UCSF has opened a state-of-the-art facility at Mission Bay that provides custom-tailored care to all patients, from professional athletes to amputees.
Presentation by Ambassador Stephen Lewis, co-director, AIDS-Free World and U.N. special envoy for HIV/AIDS in Africa (2001-2006), follow by panel discussion and reception. Lewis will be introduced by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH.
New UCSF Faculty, October 2009
New UCSF Faculty, October 2009
New UCSF Faculty, October 2009
New UCSF Faculty, October 2009
UCSF has launched a website to serve as a source of information for faculty, staff and trainees, who have questions about the medical group’s new relationship with Hill Physicians Medical Group.
New UCSF Faculty, October 2009
Dean Schillinger, director of the UCSF Center for Vulnerable Populations (CVP) at San Francisco General Hospital, received a national award for research leading to better communication in health care.
From anxiety to exhilaration to burgers with the boss, the 14 members of Elizabeth Blackburn's lab share the exciting hours surrounding the Oct. 5 Nobel Prize announcement.
A recent two-day symposium at UCSF offered leading stem cell experts a chance to talk shop and form new alliances in the fight against neurological disorders.
The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.
A collaboration between scientists at Vanderbilt University and the University of California, San Francisco has led to the first direct information about the molecular structure of prions. In addition, the study has revealed surprisingly large structural differences between natural prions and the closest synthetic analogs that scientists have created in the lab.
Actress Kathleen Turner will visit the research labs of the Rosalind Russell Arthritis Center at UCSF to gain a better understanding of the impact of autoimmune diseases and to learn firsthand about ongoing UCSF research for potential therapies.
Symbolizing a major triumph for UCSF, the University of California and the scientific community at large, molecular biologist Elizabeth Blackburn, PhD, became UCSF's fourth scientist to be tapped to receive the prestigious Nobel Prize in Physiology or Medicine.
Elizabeth Blackburn, professor emeritus in the Department of Biochemistry and Biophysics at UC San Francisco, received the 2009 Nobel Prize in Physiology or Medicine. Her research on telomeres, tiny
Molecular biologist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco, received the 2009 Nobel Prize in Physiology or Medicine on December 10th, 2009 in Stockholm, Sweden.
A roundup of coverage on Elizabeth Blackburn's Nobel Prize in Physiology or Medicine.
Molecular biologist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco, today was named to receive the 2009 Nobel Prize in Physiology or Medicine.
Scientist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco was named today (Oct. 5, 2009) to receive the 2009 Nobel Prize in Physiology or Medicine.
The 2009 Nobel Prize in Physiology or Medicine, awarded today to UCSF’s Elizabeth Blackburn, PhD – along with Carol Greider, PhD, of Johns Hopkins University School of Medicine and Jack Szostak, PhD, of Massachusetts General Hospital – recognizes the importance of the most fundamental kind of basic biological science.
UCSF's Elizabeth Blackburn, PhD, addressed the media during a news conference at the Mission Bay campus on Oct. 5, held in recognition of the announcement that she received the 2009 Nobel Prize in Physiology or Medicine